These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model. El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128 [TBL] [Abstract][Full Text] [Related]
24. Learning from HIV: how will drug resistance influence treatment strategies against hepatitis C? Durantel D; Zoulim F J HIV Ther; 2007 Dec; 12(4):88-91. PubMed ID: 18391894 [No Abstract] [Full Text] [Related]
31. Peptides: isolation, production, and use in India. Nagaraj R Biotechnol J; 2009 Mar; 4(3):329-34. PubMed ID: 19156729 [No Abstract] [Full Text] [Related]
33. Approaches for the development of antiviral compounds: the case of hepatitis C virus. Schinazi RF; Coats SJ; Bassit LC; Lennerstrand J; Nettles JH; Hurwitz SJ Handb Exp Pharmacol; 2009; (189):25-51. PubMed ID: 19048196 [TBL] [Abstract][Full Text] [Related]